Your search returned 4 results.

Results
	1.	Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting. [electronic resource] by Balu, Sanjeev Buchner, Deborah Craver, Chris Gayle, Julie Producer: 20110923 In: Clinical therapeutics vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States. [electronic resource] by Craver, Chris Gayle, Julie Balu, Sanjeev Buchner, Deborah Producer: 20110608 In: Journal of medical economics vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States. [electronic resource] by Craver, Chris Gayle, Julie Balu, Sanjeev Buchner, Deborah Producer: 20110929 In: Journal of medical economics vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States. [electronic resource] by Schwartzberg, Lee Morrow, Gary Balu, Sanjeev Craver, Chris Gayle, Julie Cox, David Producer: 20111115 In: Current medical research and opinion vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)